BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33530497)

  • 21. [Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum].
    Škapa P; Dundr P
    Cesk Patol; 2016; 52(4):199-204. PubMed ID: 27869446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian BDNF promotes survival, migration, and attachment of tumor precursors originated from p53 mutant fallopian tube epithelial cells.
    Kang M; Chong KY; Hartwich TMP; Bi F; Witham AK; Patrick D; Morrisson MJ; Cady SL; Cerchia AP; Kelk D; Liu Y; Nucci J; Madarikan O; Ueno D; Shuch BM; Yang-Hartwich Y
    Oncogenesis; 2020 May; 9(5):55. PubMed ID: 32471985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
    Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
    Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer.
    Klinkebiel D; Zhang W; Akers SN; Odunsi K; Karpf AR
    Mol Cancer Res; 2016 Sep; 14(9):787-94. PubMed ID: 27259716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follicular fluid aids cell adhesion, spreading in an age independent manner and shows an age-dependent effect on DNA damage in fallopian tube epithelial cells.
    Salvi A; Li W; Dipali SS; Cologna SM; Pavone ME; Duncan FE; Burdette JE
    Heliyon; 2024 Mar; 10(6):e27336. PubMed ID: 38501015
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Saini U; Suarez AA; Naidu S; Wallbillich JJ; Bixel K; Wanner RA; Bice J; Kladney RD; Lester J; Karlan BY; Goodfellow PJ; Cohn DE; Selvendiran K
    Cancer Res; 2018 Apr; 78(7):1739-1750. PubMed ID: 29339537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
    Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
    J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative Transcriptome Analyses of the Human Fallopian Tube: Fimbria and Ampulla-Site of Origin of Serous Carcinoma of the Ovary.
    Sowamber R; Nelson O; Dodds L; DeCastro V; Paudel I; Milea A; Considine M; Cope L; Pinto A; Schlumbrecht M; Slomovitz B; Shaw PA; George SHL
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32349388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis.
    Soong TR; Kolin DL; Teschan NJ; Crum CP
    Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30486509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model.
    Karthikeyan S; Russo A; Dean M; Lantvit DD; Endsley M; Burdette JE
    Cancer Lett; 2018 Oct; 433():221-231. PubMed ID: 29981811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer.
    Modi DA; Tagare RD; Karthikeyan S; Russo A; Dean M; Davis DA; Lantvit DD; Burdette JE
    Oncogene; 2017 May; 36(21):3015-3024. PubMed ID: 27991925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.
    Kobayashi H; Iwai K; Niiro E; Morioka S; Yamada Y; Ogawa K; Kawahara N
    Biomed Rep; 2017 Sep; 7(3):209-213. PubMed ID: 28811894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exposure of the extracellular matrix and colonization of the ovary in metastasis of fallopian-tube-derived cancer.
    Dean M; Jin V; Russo A; Lantvit DD; Burdette JE
    Carcinogenesis; 2019 Mar; 40(1):41-51. PubMed ID: 30475985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytidine deaminase Apobec3a induction in fallopian epithelium after exposure to follicular fluid.
    Brachova P; Alvarez NS; Van Voorhis BJ; Christenson LK
    Gynecol Oncol; 2017 Jun; 145(3):577-583. PubMed ID: 28215840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. γ-Glutamyl cyclotransferase contributes to tumor progression in high grade serous ovarian cancer by regulating epithelial-mesenchymal transition via activating PI3K/AKT/mTOR pathway.
    Li Y; Wu T; Wang Y; Yang L; Hu C; Chen L; Wu S
    Gynecol Oncol; 2018 Apr; 149(1):163-172. PubMed ID: 29429592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
    Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma.
    Soong TR; Howitt BE; Horowitz N; Nucci MR; Crum CP
    Gynecol Oncol; 2019 Feb; 152(2):426-433. PubMed ID: 30503267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis.
    George SH; Milea A; Sowamber R; Chehade R; Tone A; Shaw PA
    Oncogene; 2016 Jan; 35(1):59-68. PubMed ID: 25798842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
    Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
    J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.